Branched Stent Graft Market

ID: MRFR/MED/29371-HCR
128 Pages
Rahul Gotadki
Last Updated: April 24, 2026
Branched Stent Graft Market Research Report By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts, Femoral Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE), Polyester), By Endovascular Access (Transfemoral, Transradial, Subclavian) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Device Type (USD Billion)
      1. 4.1.1 Aortic Branched Stent Grafts
      2. 4.1.2 Iliac Branched Stent Grafts
      3. 4.1.3 Femoral Branched Stent Grafts
    2. 4.2 Healthcare, BY Material (USD Billion)
      1. 4.2.1 Nitinol
      2. 4.2.2 Polytetrafluoroethylene (PTFE)
      3. 4.2.3 Polyester
    3. 4.3 Healthcare, BY Endovascular Access (USD Billion)
      1. 4.3.1 Transfemoral
      2. 4.3.2 Transradial
      3. 4.3.3 Subclavian
    4. 4.4 Healthcare, BY Region (USD Billion)
      1. 4.4.1 North America
        1. 4.4.1.1 US
        2. 4.4.1.2 Canada
      2. 4.4.2 Europe
        1. 4.4.2.1 Germany
        2. 4.4.2.2 UK
        3. 4.4.2.3 France
        4. 4.4.2.4 Russia
        5. 4.4.2.5 Italy
        6. 4.4.2.6 Spain
        7. 4.4.2.7 Rest of Europe
      3. 4.4.3 APAC
        1. 4.4.3.1 China
        2. 4.4.3.2 India
        3. 4.4.3.3 Japan
        4. 4.4.3.4 South Korea
        5. 4.4.3.5 Malaysia
        6. 4.4.3.6 Thailand
        7. 4.4.3.7 Indonesia
        8. 4.4.3.8 Rest of APAC
      4. 4.4.4 South America
        1. 4.4.4.1 Brazil
        2. 4.4.4.2 Mexico
        3. 4.4.4.3 Argentina
        4. 4.4.4.4 Rest of South America
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC Countries
        2. 4.4.5.2 South Africa
        3. 4.4.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Gore Medical (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Cook Medical (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boston Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Terumo Corporation (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Abbott Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun Melsungen AG (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 JOTEC GmbH (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY DEVICE TYPE
    4. 6.4 US MARKET ANALYSIS BY MATERIAL
    5. 6.5 US MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    6. 6.6 CANADA MARKET ANALYSIS BY DEVICE TYPE
    7. 6.7 CANADA MARKET ANALYSIS BY MATERIAL
    8. 6.8 CANADA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    9. 6.9 EUROPE MARKET ANALYSIS
    10. 6.10 GERMANY MARKET ANALYSIS BY DEVICE TYPE
    11. 6.11 GERMANY MARKET ANALYSIS BY MATERIAL
    12. 6.12 GERMANY MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    13. 6.13 UK MARKET ANALYSIS BY DEVICE TYPE
    14. 6.14 UK MARKET ANALYSIS BY MATERIAL
    15. 6.15 UK MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    16. 6.16 FRANCE MARKET ANALYSIS BY DEVICE TYPE
    17. 6.17 FRANCE MARKET ANALYSIS BY MATERIAL
    18. 6.18 FRANCE MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    19. 6.19 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    20. 6.20 RUSSIA MARKET ANALYSIS BY MATERIAL
    21. 6.21 RUSSIA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    22. 6.22 ITALY MARKET ANALYSIS BY DEVICE TYPE
    23. 6.23 ITALY MARKET ANALYSIS BY MATERIAL
    24. 6.24 ITALY MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    25. 6.25 SPAIN MARKET ANALYSIS BY DEVICE TYPE
    26. 6.26 SPAIN MARKET ANALYSIS BY MATERIAL
    27. 6.27 SPAIN MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    28. 6.28 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    29. 6.29 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
    30. 6.30 REST OF EUROPE MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    31. 6.31 APAC MARKET ANALYSIS
    32. 6.32 CHINA MARKET ANALYSIS BY DEVICE TYPE
    33. 6.33 CHINA MARKET ANALYSIS BY MATERIAL
    34. 6.34 CHINA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    35. 6.35 INDIA MARKET ANALYSIS BY DEVICE TYPE
    36. 6.36 INDIA MARKET ANALYSIS BY MATERIAL
    37. 6.37 INDIA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    38. 6.38 JAPAN MARKET ANALYSIS BY DEVICE TYPE
    39. 6.39 JAPAN MARKET ANALYSIS BY MATERIAL
    40. 6.40 JAPAN MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    41. 6.41 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    42. 6.42 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
    43. 6.43 SOUTH KOREA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    44. 6.44 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    45. 6.45 MALAYSIA MARKET ANALYSIS BY MATERIAL
    46. 6.46 MALAYSIA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    47. 6.47 THAILAND MARKET ANALYSIS BY DEVICE TYPE
    48. 6.48 THAILAND MARKET ANALYSIS BY MATERIAL
    49. 6.49 THAILAND MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    50. 6.50 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    51. 6.51 INDONESIA MARKET ANALYSIS BY MATERIAL
    52. 6.52 INDONESIA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    53. 6.53 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    54. 6.54 REST OF APAC MARKET ANALYSIS BY MATERIAL
    55. 6.55 REST OF APAC MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    56. 6.56 SOUTH AMERICA MARKET ANALYSIS
    57. 6.57 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    58. 6.58 BRAZIL MARKET ANALYSIS BY MATERIAL
    59. 6.59 BRAZIL MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    60. 6.60 MEXICO MARKET ANALYSIS BY DEVICE TYPE
    61. 6.61 MEXICO MARKET ANALYSIS BY MATERIAL
    62. 6.62 MEXICO MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    63. 6.63 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    64. 6.64 ARGENTINA MARKET ANALYSIS BY MATERIAL
    65. 6.65 ARGENTINA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
    68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    69. 6.69 MEA MARKET ANALYSIS
    70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
    72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
    75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    76. 6.76 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    77. 6.77 REST OF MEA MARKET ANALYSIS BY MATERIAL
    78. 6.78 REST OF MEA MARKET ANALYSIS BY ENDOVASCULAR ACCESS
    79. 6.79 KEY BUYING CRITERIA OF HEALTHCARE
    80. 6.80 RESEARCH PROCESS OF MRFR
    81. 6.81 DRO ANALYSIS OF HEALTHCARE
    82. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    83. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    84. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
    85. 6.85 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    86. 6.86 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    87. 6.87 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
    88. 6.88 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
    89. 6.89 HEALTHCARE, BY ENDOVASCULAR ACCESS, 2024 (% SHARE)
    90. 6.90 HEALTHCARE, BY ENDOVASCULAR ACCESS, 2024 TO 2035 (USD Billion)
    91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.2.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.3.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.4.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.5.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.6.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.7.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.8.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.9.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.10.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.11.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.12.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.13.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.14.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.15.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.16.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.17.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.18.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.19.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.20.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.21.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.22.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.23.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.24.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.25.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.26.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.27.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.28.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.29.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY MATERIAL, 2025-2035 (USD Billion)
      3. 7.30.3 BY ENDOVASCULAR ACCESS, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Device Type (USD Billion, 2025-2035)

  • Aortic Branched Stent Grafts
  • Iliac Branched Stent Grafts
  • Femoral Branched Stent Grafts

Healthcare By Material (USD Billion, 2025-2035)

  • Nitinol
  • Polytetrafluoroethylene (PTFE)
  • Polyester

Healthcare By Endovascular Access (USD Billion, 2025-2035)

  • Transfemoral
  • Transradial
  • Subclavian